2017 FDA drug approvals
Nature Reviews Drug Discovery 17, 150 (2018).
doi:10.1038/nrd.2018.18
Author: Asher Mullard
Nature Reviews Drug Discovery17, 81–85 (2018)Semaglutide is the sixth GLP1 agonist to receive FDA approval, not the fifth as originally noted. This correction has been made in the print and online versions.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Asher Mullard Tags: Corrigendum Source Type: research
More News: Drugs & Pharmacology